Navigation Links
Resveratrol Longevity Science Makes Dramatic U-Turn, But Resveratrol Supplements Remain Unchanged
Date:9/10/2008

sume about 35% fat calories). The fat-engorged mice did live longer on resveratrol, but this experiment is not comparable to humans eating a normal diet. [Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006 Nov 16; 444(7117):337-42]

The Sirtuin1 gene does not appear to be the "holy grail" of longevity by itself, as once claimed. The Sirtuin family of genes works in tandem with other genes, such as FOXO1 and PGc1alpha. [Interaction of aging-associated signaling cascades: inhibition of NF-kappaB signaling by longevity factors Foxos and SIRT1. Cell Mol Life Science. 2008 Apr; 65(7-8):1049-58; Acetylation of Foxo1 alters its DNA-binding ability and sensitivity to phosphorylation. Proceedings National Academy of Science: 2005 Aug 9; 102(32):11278-83]

Nor does a singular molecule such as resveratrol appear to work as well as resveratrol combined with quercetin or other small molecules. [Combined resveratrol, quercetin, and catechin treatment reduces breast tumor growth in a nude mouse model. Translational Oncology 2008 March; 1(1):19-27; Enhanced inhibition of adipogenesis and induction of apoptosis in 3T3-L1 adipocytes with combinations of resveratrol and quercetin. Life Science 2008 May 7; 82(19-20):1032-9]

Sardi says other key genes, particularly the FOXO1 gene, which plays a key role in a variety of biological processes, including metabolism, cell proliferation, and oxidative stress response, may play a stronger role than the Sirtuin1 gene in producing longevity.

At the National Library of Medicine online there are now 706 published journal reports on FOXO1, and 471 on Sirtuin1. In the gene array study published in the September 2008 issue of Experimental Gerontology, only Longevinex(R), and not calorie restriction of plain resveratrol, activated the FOXO1 gene.

Longevinex(R) has since abandoned the Sirtuin1 gene activation test as a measure of dietary supplement activity. In the Longevinex(R) mouse s
'/>"/>

SOURCE Resveratrol Partners, LLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Video: Resveratrol-based Nutriceutical (Longevinex(R)) Induces Favorable Changes on Gene Expression in Mouse Heart At Doses 17-320 Times Lower Than Prior Studies
2. Epiphany Biosciences to Continue Phase 2 Shingles Study After Interim Analysis; Plans Follow-On Clinical Trial Studying Post-Herpetic Neuralgia (PHN)
3. Ardea Biosciences to Present Data on Lead MEK Inhibitor, RDEA119, at American College of Gastroenterology Annual Scientific Meeting
4. Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS)
5. Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis
6. Human Genome Sciences Reports Initial Results of Randomized Phase 2 Trial of HGS-ETR1 in Combination With Bortezomib in Advanced Multiple Myeloma
7. Regado Biosciences Reports Clinical Results for REG1 Anticoagulation System at European Society of Cardiology Congress 2008
8. Stem Cell Sciences Announces the Creation of the Worlds First Authentic Rat Embryonic Stem Cells from its Exclusively Licensed Technology
9. Neurosciences Institute Discovers Drug Extends Stroke Treatment Time to 24 Hours, Repairs Brain Tissue
10. Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial
11. Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...The Netherlands and JOHANNESBURG, November 25 /PRN...ion and Pyxis Discovery announced today,that they ...arket both,companies, services. , Pyxis,s...overy expertise,will be coupled with iThemba,s ser...hemistry support to projects identified through Py...
(Date:11/25/2009)...Calif., Nov. 25 ChemoCentryx, In...a from the Company,s PROTECT-1 (the Prospective Ra...e Trial) of Traficet-EN(TM) (CCX282-B) in patients...ted clinical efficacy with a favorable safety and ...ence of clinical efficacy in the reduction of dise...
(Date:11/24/2009)...ov. 24 ,, WHAT: Rom Houbens, ...years following an auto accident, was actually ful...e subject of a Good Morning America segment. The ...strate how people with Locked-in Syndrome and othe... Good Morning America -- Tuesday, November 24 a...
Breaking Medicine Technology:iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Arizona Heart Institute Enrolls First Patient in Anaconda 28TM 29 Investigational Study for the Treatment of Abdominal Aortic Aneurysm 49462 1Arizona Heart Institute Enrolls First Patient in Anaconda 28TM 29 Investigational Study for the Treatment of Abdominal Aortic Aneurysm 49462 2Arizona Heart Institute Enrolls First Patient in Anaconda 28TM 29 Investigational Study for the Treatment of Abdominal Aortic Aneurysm 49462 3Lytix Biopharma and KAEL GemVax Announce Joint Clinical Trial to Combine LTX 315 and GV1001 Cancer Immunotherapy 12707 1Lytix Biopharma and KAEL GemVax Announce Joint Clinical Trial to Combine LTX 315 and GV1001 Cancer Immunotherapy 12707 2NeuroTherm Completes Acquisition of the Micron Epidural Catheter 49458 1NeuroTherm Completes Acquisition of the Micron Epidural Catheter 49458 2
...tigator Meeting for European Participants in Phase...d Population, BERKELEY HEIGHTS, N.J., Sept. 5 /PR... GNTA ) announced that data from the Company,s Pha...s chemotherapy would be,presented at the opening s...ing organized by the European Association of Derma...
... Data Scheduled for Presentation at 47th ICAAC on ...ARLSBAD, Calif., Sept. 4 Ardea Biosciences,Inc. (...cessfully completed,Phase 1 single-ascending-dose,...teraction studies of RDEA806, a novel HIV non-nucl... healthy volunteers. The data from these Phase 1 ...
Other Medicine Technology:Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology 2Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology 3Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology 4Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology 5Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806 2Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806 3
(Date:11/27/2009)...C, Nov. 27 /PRNewswire/ - Uploadable USB pedometer...e in wellness. A combination of advanced accelerom...olving a long term concern over the accuracy of se...gauge and reward improved participation in a fitne...f the first wellness suppliers to integrate this t...
(Date:11/27/2009)...SCO, Nov. 27 The Gymbore...r Lambert, CFO/COO, will present at the NASDAQ OMX...May Fair Hotel in London, England, on Wednesday, D...n to a live broadcast of The Gymboree Corporation,... www.gymboree.com, click on "Our Company" at the b...
(Date:11/27/2009)...AMIR, Israel, Nov. 27 Sh...mir" ), a leading provider of innovative products ...unced today that its board of directors had declar...of US$ 10 million (approximately NIS 37.62 million...e of exchange), or approximately US$ 0.609 (approx...
(Date:11/27/2009)...g unprecedented medical, economic burdens, study p...ews) -- The number of people with diabetes in the ...25 years, a new study predicts. , That would br... with the disease, up from 23.7 million today. , ...ith diabetes will triple, the study also warns, ri...
(Date:11/27/2009)... Multi-purpose bilingual coloring books design...the business community to educate - inform parents...Safety issues to Dinosuars to ABC,S and a host of ...is, MO (PRWEB) November 27, 2009 -- Today’s ...to keep them busy any hour of the day, but one of ...
Breaking Medicine News(10 mins):Health News:New USB technology adds accountability and convenience to wellness programs 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2
...oea Association (BSSAA) reveals that snoring affec...a detrimental effect on health and ruins sex lives... has brought out an anti snore bedroom which has s...dy conducted by the BSSAA, 15 million people in th...
...kins today unanimously voted to support behind Mar... indoor public spaces in the state. A resol...kins Medicine Board of Trustees stated that the Bo...legislation banning smoking in all indoor public s...
...ed fish are enormous and especially children and w...how much// and which fish they eat says-"The Madis...ay in a special issue of the international science...is a synopsis of the latest scientific knowledge a...
...are among a variety of autoimmune diseases that ar...lled the immune regulatory// cell, malfunctions. I...mutation in the FOXP3 gene disables the immune cel...ty of Pennsylvania School of Medicine have discove...
...n lead to inappropriate treatment for their childr...ns Hopkins// University undergraduate in Africa co... – interviews, stool samples and medical records –...ent diarrheal disease or manage it. Diarrhe...
...onic stem cells to send cannibalistic signals to h...he way for normal mammalian// development. A...d or damaged parts. It was known to be active in c...ctually help keep cells alive. The novel rol...
Other Medicine News:Health News:Johns Hopkins Medicine Trustees Support Smoking Ban In Public Spaces 2Health News:Methylmercury in Marine Fish Pose Health Risks to Pregnant Women and Elderly Men 2Health News:Methylmercury in Marine Fish Pose Health Risks to Pregnant Women and Elderly Men 3Health News:Researchers Discover New Molecular Path to Fight Autoimmune Diseases 2Health News:Mothers in African Study Undereducated on Diarrhea 2Health News:Mothers in African Study Undereducated on Diarrhea 3Health News:Cannibalistic Signals Help Mammalian Embryos Develop Normally 2Health News:Cannibalistic Signals Help Mammalian Embryos Develop Normally 3
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
Medicine Products: